Multicenter real-world experience of the clinical efficacy and tolerance of pazopanib in high-risk pediatric solid tumors (PazoPed).
Sign Up to like & getrecommendations! Published in 2023 at "Pediatric hematology and oncology"
DOI: 10.1080/08880018.2023.2182854
Abstract: Pazopanib, a receptor tyrosine kinase inhibitor, exhibits anti-tumor activity in adult bone and soft-tissue sarcomas (STS), but has not yet been approved for pediatric tumors. The primary objective was to evaluate pazopanib efficacy when used… read more here.
Keywords: pazopanib; multicenter real; efficacy; solid tumors ... See more keywords
Overall Survival of Nonmetastasized NSCLC Patients Treated With Add-On Viscum album L: A Multicenter Real-World Study
Sign Up to like & getrecommendations! Published in 2020 at "Integrative Cancer Therapies"
DOI: 10.1177/1534735420940384
Abstract: Background: Recent data suggest a beneficial effect of add-on treatment with Viscum album L (VA) on the survival in cancer patients. The objective of this study was to compare the impact of standard oncological therapy… read more here.
Keywords: overall survival; multicenter real; nsclc patients; study ... See more keywords